Inception Return
(1/2/2001)
|
4.03 %
|
|
YTD Return
|
-2.50 %
|
|
NAVPS
(5/7/2021)
|
$11.37
|
|
Change
|
$0.12 / 1.04 %
|
|
|
Growth of $10,000
(As of March 31, 2021)
|
|
MER
|
2.40 %
|
|
Assets ($mil)
|
$1,390.47
|
|
Rank (1Yr)
|
744/797
|
|
Std Dev (3Yr)
|
10.03 %
|
|
Volatility Ranking (3Yr)
|
4/10
|
|
RRSP Eligibility
|
Yes
|
|
Load
|
Choice of Front or Back
|
|
Max Front End
|
5.00 %
|
|
Max Back End
|
5.50 %
|
|
Sales Status
|
Open
|
|
|
Objective
The Fund seeks to provide long-term capital growth through capital appreciation by investing primarily in a diversified portfolio of equity securities of foreign companies located in Europe, the Far East, and the Pacific Rim.
|
Management Co.
CIBC Asset Management Inc.
Managers
-
Roy Leckie, Walter Scott and Partners Limited
-
Charles Macquaker, Walter Scott and Partners Limited
|
|
Asset Allocation
(As of March 31, 2021)
|
Sector Allocation
(As of March 31, 2021)
|
Geographic Allocation
(As of March 31, 2021)
|
Top 10 Holdings
| Name | Asset | Sector | Geographic | Percent |
| Cash and Cash Equivalents | Cash and Equivalents | Cash and Cash Equivalent | Canada | 4.47% |
| Taiwan Semiconductor Manufacturing Co Ltd - ADR | International Equity | Technology | Asia/Pacific Rim | 3.12% |
| AIA Group Ltd | International Equity | Financial Services | Asia/Pacific Rim | 2.48% |
| Jardine Matheson Holdings Ltd | International Equity | Industrial Goods | Latin America | 2.46% |
| ASML Holding NV | International Equity | Technology | European Union | 2.46% |
| Novo Nordisk A/S Cl B | International Equity | Healthcare | European Union | 2.42% |
| Roche Holding AG - Participation | International Equity | Healthcare | Other European | 2.37% |
| Keyence Corp | International Equity | Industrial Goods | Japan | 2.33% |
| Diageo PLC | International Equity | Consumer Goods | European Union | 2.25% |
| adidas AG | International Equity | Consumer Goods | European Union | 2.25% |
Performance Data
(As of March 31, 2021)
|
|
Return (%)
|
Annualized Return (%)
|
|
Return
|
1
Mth
|
3
Mth
|
6
Mth
|
YTD
|
1
Yr
|
3
Yr
|
5
Yr
|
10
Yr
|
|
Fund
|
0.74
|
-2.50
|
2.82
|
-2.50
|
19.65
|
8.43
|
10.00
|
8.55
|
|
Benchmark
|
1.19
|
2.09
|
14.32
|
2.09
|
31.80
|
5.61
|
8.73
|
8.84
|
|
Quartile Ranking
|
3
|
4
|
4
|
4
|
4
|
1
|
1
|
2
|
|
Calendar Return (%)
|
2020
|
2019
|
2018
|
2017
|
2016
|
2015
|
2014
|
2013
|
2012
|
2011
|
|
Fund
|
14.52
|
18.75
|
-1.75
|
17.00
|
-0.16
|
16.74
|
2.01
|
15.98
|
16.92
|
-9.27
|
|
Benchmark
|
8.01
|
16.27
|
-6.81
|
18.38
|
-1.70
|
19.41
|
4.12
|
32.41
|
14.58
|
-10.59
|
|
Quartile Ranking
|
1
|
2
|
1
|
3
|
2
|
3
|
3
|
4
|
2
|
1
|
MSCI ESG Fund Metrics (As of April 01, 2021)
|
The MSCI ESG Quality Score measures the ability of underlying holdings to manage key medium to long-term risks and opportunities arising from environmental, social, and governance factors.
|
|
The percentage of the portfolio's market value exposed to companies flagged for one or more standard SRI exclusion factors (alcohol, civilian firearms, gambling, weapons, cluster bombs, landmines, nuclear power, GMOs, and tobacco).
|
The portfolio weighted average of each company’s percent of revenue generated by Sustainable Impact Solutions (goods and services that address at least one of the world’s social and environmental challenges), as defined by the United Nations Sustainable Development Goals.
|
ESG data provided by MSCI
MSCI ESG Research LLC’s (“MSCI ESG”) Fund Metrics products (the “Information”) provide environmental, social and governance data with respect to underlying securities within more than 23,000 multi-asset class Mutual Funds and ETFs globally. MSCI ESG is a Registered Investment Adviser under the Investment Advisers Act of 1940. MSCI ESG materials have not been submitted to, nor received approval from, the US SEC or any other regulatory body. None of the Information constitutes an offer to buy or sell, or a promotion or recommendation of, any security, financial instrument or product or trading strategy, nor should it be taken as an indication or guarantee of any future performance, analysis, forecast or prediction. None of the Information can be used to determine which securities to buy or sell or when to buy or sell them. The Information is provided “as is” and the user of the Information assumes the entire risk of any use it may make or permit to be made of the Information.